Acura Pharmaceuticals, Inc.
Acura Pharmaceuticals, Inc. (ACUR) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · ACUR · as of Jun 9, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Acura Pharmaceuticals, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
ACUR insider buying and selling by quarter
ACUR insider selling · ACUR insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · ACUR ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
ACUR executive sell shares · ACUR board member insider trading · ACUR insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jan 2, 2026 | THANGARAJ IMMANUEL Director | Option | 50,000 | $500 | Form 4 |
| Jan 2, 2026 | SKELLY WILLIAM G Director | Option | 50,000 | $500 | Form 4 |
| Jan 2, 2026 | ROSS GEORGE K Director | Option | 50,000 | $500 | Form 4 |
| Jan 2, 2025 | THANGARAJ IMMANUEL Director | Option | 50,000 | $500 | Form 4 |
| Jan 2, 2025 | SKELLY WILLIAM G Director | Option | 50,000 | $500 | Form 4 |
| Jan 2, 2025 | ROSS GEORGE K Director | Option | 50,000 | $500 | Form 4 |
| Jan 2, 2024 | ROSS GEORGE K Director | Option | 50,000 | $500 | Form 4 |
| Jan 2, 2024 | SKELLY WILLIAM G Director | Option | 50,000 | $500 | Form 4 |
| Jan 2, 2024 | THANGARAJ IMMANUEL Director | Option | 50,000 | $500 | Form 4 |
| Jan 2, 2024 | WESSON BRUCE F Director | Option | 37,500 | $375 | Form 4 |
| Nov 20, 2023 | Seiser Robert A VP, Treasurer & Controller | Option | 40,000 | $400 | Form 4 |
| Nov 20, 2023 | Jones Robert B President & CEO | Option | 40,000 | $400 | Form 4 |
| Nov 20, 2023 | CLEMENS PETER A Senior VP & CFO | Option | 40,000 | $400 | Form 4 |
| Nov 20, 2023 | Brzeczko Albert W See Remarks | Option | 40,000 | $400 | Form 4 |
| Jan 3, 2023 | Seiser Robert A VP, Treasurer & Controller | Option | 20,000 | — | Form 4 |
| Jan 3, 2023 | Jones Robert B President & CEO | Option | 50,000 | — | Form 4 |
| Jan 3, 2023 | CLEMENS PETER A Senior VP & CFO | Option | 40,000 | — | Form 4 |
| Jan 3, 2023 | Brzeczko Albert W See Remark | Option | 34,000 | — | Form 4 |
| Jan 3, 2023 | ROSS GEORGE K Director | Option | 66,666 | — | Form 4 |
| Jan 3, 2023 | WESSON BRUCE F Director | Option | 66,666 | — | Form 4 |
| Jan 3, 2023 | THANGARAJ IMMANUEL Director | Option | 66,666 | — | Form 4 |
| Jan 3, 2023 | SKELLY WILLIAM G Director | Option | 66,666 | — | Form 4 |
| Aug 3, 2022 | Brzeczko Albert W VP, Pharma Sciences - APT | Option | 43,333 | $433 | Form 4 |
| Aug 3, 2022 | Brzeczko Albert W VP, Pharma Sciences - APT | Option | 43,333 | — | Form 4 |
| Aug 3, 2022 | Jones Robert B President & CEO | Option | 63,666 | — | Form 4 |
Seiser Robert A
VP, Treasurer & Controller
Date
Nov 20
Shares
40,000
Price
$0.01
Value
$400
Seiser Robert A
VP, Treasurer & Controller
Date
Jan 3
Shares
20,000
Price
—
Value
—
Brzeczko Albert W
VP, Pharma Sciences - APT
Date
Aug 3
Shares
43,333
Price
$0.01
Value
$433
Brzeczko Albert W
VP, Pharma Sciences - APT
Date
Aug 3
Shares
43,333
Price
—
Value
—
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About ACUR insider trading
ACUR insider trades
Acura Pharmaceuticals, Inc. (ACUR) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including THANGARAJ IMMANUEL (Director), SKELLY WILLIAM G (Director), ROSS GEORGE K (Director). Over the past 12 months, 3 insiders have filed transactions with the SEC. ACUR insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Acura Pharmaceuticals, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
ACUR insider trading · 5 questionsThe insiders of Acura Pharmaceuticals, Inc. (ACUR) include executives and directors such as THANGARAJ IMMANUEL (Director), SKELLY WILLIAM G (Director), ROSS GEORGE K (Director), among others. Over the past 12 months, 3 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026